Ubs Oconnor LLC Stryker Corp Transaction History

Ubs Oconnor LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$246.13 - $285.47 $723,376 - $838,996	-2,939 Reduced 69.61%	1,283 $366,000
Q4 2022 Feb 14, 2023	SELL	$205.51 - $253.93 $966,513 - $1.19 Million	-4,703 Reduced 52.69%	4,222 $0
Q3 2022 Nov 14, 2022	SELL	$189.27 - $231.83 $1.1 Million - $1.34 Million	-5,800 Reduced 39.39%	8,925 $1.81 Billion
Q2 2022 Aug 12, 2022	BUY	$194.09 - $276.37 $2.86 Million - $4.07 Million	14,725 New	14,725 $2.93 Million

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $148B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.